V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210038001 | 210006648 | 0 | 64 | Curative (C) | 2016-10-15 | 2016-12-05 | Methotrexate intrathecal | N | N | 210010708 | METHOTREXATE INTRATHECAL |
| 210038003 | 210006674 | 1.77 | 19.4 | Curative (C) | 2017-10-06 | 2018-02-01 | Methotrexate Intrathecal (any age) | N | N | 210010778 | METHOTREXATE INTRATHECAL |
| 210038004 | 210006687 | null | 17.3 | Curative (C) | 2017-01-03 | 2017-07-07 | Methotrexate intrathecal | N | N | 210010787 | METHOTREXATE INTRATHECAL |
| 210038005 | 210006693 | null | 26.9 | Curative (C) | 2016-06-20 | 2016-06-20 | Methotrexate intrathecal | N | N | 210010803 | METHOTREXATE INTRATHECAL |
| 210038006 | 210006699 | 0 | 19.6 | Adjuvant (A) | 2017-08-13 | 2017-12-11 | Methotrexate intrathecal | 02 | N | 210010804 | METHOTREXATE INTRATHECAL |
| 210038007 | 210018587 | 1.07 | 82 | Disease modification (D) | 2014-03-03 | 2014-09-14 | Methotrexate intrathecal | Y | N | 210010872 | METHOTREXATE INTRATHECAL |
| 210038008 | 210006722 | null | 52 | Curative (C) | 2014-08-13 | 2014-09-19 | UKALL14- Ph 2 Induction | N | N | 210010917 | UKALL2014 |
| 210038009 | 210030350 | 1.75 | 45 | Disease modification (D) | 2016-09-24 | 2017-01-23 | UKALL14- Ph 2 Induction | N | N | 210010923 | UKALL2014 |
| 210038010 | 210006745 | null | 85 | Curative (C) | 2015-10-24 | 2016-07-29 | UKALL14- Ph 2 Induction | Y | null | 210010965 | UKALL2014 |
| 210038011 | 210006750 | 1.82 | 103 | Adjuvant (A) | 2015-05-03 | 2015-08-11 | UKALL14- Ph 2 Induction | N | N | 210010967 | UKALL2014 |
| 210038012 | 210006755 | 1.69 | 70.1 | Curative (C) | 2014-07-02 | 2014-07-06 | UKALL14- Ph 2 Induction | Y | N | 210010969 | UKALL2014 |
| 210038013 | 210006762 | 1.82 | null | Curative (C) | 2018-04-06 | 2018-11-14 | UKALL14- Intens/CNS Proph | 2 | N | 210010978 | UKALL2014 |
| 210038014 | 210006769 | 1.83 | 60.7 | Curative (C) | 2016-03-06 | 2016-03-06 | UKALL14- Ph 2 Induction | Y | N | 210010983 | UKALL2014 |
| 210038015 | 210006776 | 1.79 | null | Neo-adjuvant (N) | 2018-07-30 | 2019-02-10 | UKALL14- Ph 2 Induction | Y | N | 210010999 | UKALL2014 |
| 210038016 | 210006781 | null | 104 | Adjuvant (A) | 2013-11-27 | 2013-11-29 | UKALL14- Maintenance | Y | N | 210011010 | UKALL2014 |
| 210038017 | 210018643 | 1.64 | 77.3 | Curative (C) | 2013-03-09 | 2014-01-15 | UKALL14- Cons Cycle 2 | Y | N | 210011043 | UKALL2014 |
| 210038018 | 210018646 | 1.94 | 94.2 | Curative (C) | 2018-07-30 | 2018-09-07 | UKALL14- Maintenance | Y | N | 210011049 | UKALL2014 |
| 210038019 | 210006810 | 1.71 | 80.8 | Palliative (P) | 2016-05-22 | 2016-05-22 | UKALL14- FMC (2 day) Conditioning | null | N | 210011068 | UKALL2014 |
| 210038020 | 210006814 | 1.69 | null | Palliative (P) | 2015-06-10 | 2015-09-10 | UKALL14- Maintenance | Y | N | 210011080 | UKALL2014 |
| 210038021 | 210006817 | 1.75 | 73.5 | Curative (C) | 2018-05-01 | 2018-07-31 | UKALL14- Cons Cycle 3 | 01 | N | 210011090 | UKALL2014 |
| 210038022 | 210006825 | 1.6 | 67 | Palliative (P) | 2018-05-12 | 2018-05-12 | UKALL14- Ph 2 Induction | 01 | N | 210011103 | UKALL2014 |
| 210038024 | 210006848 | 1.69 | 59.3 | Curative (C) | 2017-05-05 | 2017-10-28 | UKALL14- Cons Cycle 1 | 1 | N | 210011203 | UKALL2014 |
| 210038025 | 210018693 | 1.62 | 36 | Curative (C) | 2018-04-06 | 2018-07-06 | UKALL14- Maintenance | N | N | 210011220 | UKALL2014 |
| 210038026 | 210006869 | 1.62 | 70.15 | Curative (C) | 2015-03-06 | 2015-03-06 | UKALL14- Maintenance | 01 | N | 210011259 | UKALL2014 |
| 210038028 | 210006874 | 0.92 | 44.2 | Curative (C) | 2015-09-10 | 2016-06-24 | CNS ATRT Dox | N | N | 210011276 | NOT MATCHED |
| 210038029 | 210006876 | 0 | 42.5 | Curative (C) | 2014-05-21 | 2015-01-04 | CNS Ependymoma II Vinc/HD MTX | Y | N | 210011282 | NOT MATCHED |
| 210038030 | 210006890 | 0 | 27.2 | Curative (C) | 2014-07-14 | 2014-07-29 | CNS Medbl Std Risk weekly vinc+ xrt | Y | N | 210011346 | NOT MATCHED |
| 210038031 | 210006905 | 1.22 | 50.9 | Curative (C) | 2017-08-19 | 2017-08-20 | ALL Ph+ve Das1st/2nd Rind IIA Pasp | 2 | null | 210011405 | NOT MATCHED |
| 210038032 | 210006924 | 1.64 | 9.1 | Curative (C) | 2018-03-29 | 2018-09-03 | CNS Medbl HR Cisplatin/Vinc/Cyclophos/GCSF | N | N | 210011458 | NOT MATCHED |
| 210038033 | 210018743 | 0 | 0 | Disease modification (D) | 2018-01-15 | 2018-01-31 | CNS VINILO (trial) Weekly Vinblastine | N | N | 210011483 | NOT MATCHED |
| 210038034 | 210006954 | 1.43 | null | Curative (C) | 2015-09-05 | 2015-09-06 | CNS High Grade Glioma PCV | 02 | N | 210011597 | NOT MATCHED |
| 210038035 | 210006961 | null | 88.4 | Curative (C) | 2017-05-11 | 2017-12-22 | CNS Epen2007 09 Baby Brn vinc+cyclo | Y | N | 210011644 | NOT MATCHED |
| 210038036 | 210025976 | 0 | 49.3 | Curative (C) | 2014-12-24 | 2015-02-04 | ALL Interfant 06 Ind Erw asp 8-35 | Y | N | 210011690 | NOT MATCHED |
| 210038037 | 210018777 | 1.78 | 23.1 | Curative (C) | null | 2016-04-08 | CNS Epen2007 09 Baby Brn vinc+cyclo | Y | N | 210011746 | NOT MATCHED |
| 210038038 | 210025986 | 1.6 | 74.3 | Curative (C) | 2015-06-16 | 2015-08-01 | CNS Headstart II A Ind 4,5 int | 1 | N | 210011774 | NOT MATCHED |
| 210038039 | 210006998 | 1.33 | 14.3 | Curative (C) | 2016-03-02 | 2016-09-20 | CNS Headstart II A Ind 4,5 int | Y | N | 210011796 | NOT MATCHED |
| 210038040 | 210018790 | 0 | 27.8 | Curative (C) | null | 2017-04-07 | CNS High Grade Glioma PCV | 1 | Y | 210011798 | NOT MATCHED |
| 210038041 | 210018800 | 1.4 | 15.3 | Curative (C) | 2018-03-23 | 2018-05-30 | CNS Epen2007 09 Baby Brn vinc+cyclo | 99 | null | 210011898 | NOT MATCHED |
| 210038043 | 210007027 | null | 65.599 | Curative (C) | 2019-01-29 | 2019-02-02 | CNS Epen2007 09 Baby Brn vinc+Mtx | 02 | null | 210011965 | NOT MATCHED |
| 210038044 | 210007032 | 0 | 59.4 | Curative (C) | 2015-05-27 | 2015-11-08 | CNS High Grade Glioma PCV | N | N | 210011976 | NOT MATCHED |
| 210038045 | 210007050 | 0 | 23.1 | Curative (C) | 2016-01-10 | 2016-01-10 | CNS Ependy II Cisplatin + valproate | N | N | 210012048 | NOT MATCHED |
| 210038046 | 210007056 | 0 | 30.5 | Curative (C) | 2014-09-26 | 2014-09-26 | CNS LGG 2004 03 cons vinc + carbo | N | N | 210012051 | NOT MATCHED |
| 210038048 | 210018846 | null | 28.8 | Disease modification (D) | 2015-11-11 | 2015-11-11 | ALL Interfant 06 OCTADAD pt I PAsp | N | N | 210012147 | NOT MATCHED |
| 210038049 | 210033112 | 0 | null | Curative (C) | 2014-02-10 | 2015-07-24 | ALL UKALL2011 Ind B Sht Dex (Erw) | N | N | 210012198 | NOT MATCHED |
| 210038050 | 210007105 | 0 | 22.4 | Curative (C) | 2018-03-02 | 2018-10-17 | ALL Int GdeC AugBFMCon PhII pt1PAsp | N | N | 210012268 | NOT MATCHED |
| 210038051 | 210007108 | 1.83 | 14.1 | Curative (C) | 2018-11-14 | 2018-11-25 | CNS Ependymoma II Vinc/Cyclophos + valproate | 02 | N | 210012274 | NOT MATCHED |
| 210038052 | 210030492 | 1.82 | 15.65 | Adjuvant (A) | 2015-03-30 | 2015-04-27 | ALL ALLR3: Alt HR Con:Wk 6 ErwHDMtx | Y | null | 210012295 | NOT MATCHED |
| 210038053 | 210007122 | 1.89 | 102 | Adjuvant (A) | 2015-04-17 | 2015-05-06 | PCV | 02 | N | 210012299 | PCV |
| 210038055 | 210007148 | 1.87 | 115 | Palliative (P) | 2014-12-29 | 2014-12-29 | PCV | 02 | N | 210012446 | PCV |
| 210038056 | 210007176 | 1.69 | 65.5 | Curative (C) | 2018-08-01 | 2018-08-01 | Trial Unspecified | Y | N | 210012572 | TRIAL |